Raid Ibrahim

Raid Ibrahim has extensive experience in global regulatory affairs, currently serving as Director of Global Regulatory Strategy at AbbVie since June 2014. This role involves managing regulatory strategies for Oncology and Hematology across the US and Canada, coordinating submissions of regulatory documentation, and overseeing regulatory maintenance for IND and NDA. Prior to AbbVie, Raid held various scientific and managerial positions at Abbott Laboratories, Eli Lilly and Company, and Wyeth Pharmaceuticals, with a strong focus on analytical method development, regulatory submissions, and quality control across multiple therapeutic areas. Education includes a Biotechnology Quality and Regulatory Compliance Certificate and a Master's degree in Chemistry.